−1.69EUR
−31.225MEUR
3.084MEUR
10.984M
About NYXOAH SA
Sector
Industry
CEO
Olivier Taelman
Website
Headquarters
Mont-Saint-Guibert
Employees (FY)
137
Founded
2009
ISIN
BE0974358906
Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
